Bank7 Corp. (BSVN) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BSVN SEC filings page.
Bank7 Corp. (BSVN) reported $98.4M in revenue over the twelve months to Jun 30, 2026, up 2.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Bank7’s dominant mechanic is balance-sheet expansion funded by liabilities, while high profitability became less efficient as capital accumulated.
Assets rose to$1.96B in FY2025 even as revenue and net income softened. That combination pulled ROA down to2.2% from2.6% , showing added balance-sheet scale did not translate proportionally into earnings.
Debt-to-equity declined from 7.2x to 6.8x even as liabilities increased. Equity rose from
Operating cash flow exceeded net income in both FY2024 and FY2025, indicating earnings were accompanied by cash generation. Yet free cash flow fell from
Financial Health Signals
Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Bank7 Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Bank7 Corp. earned a return on assets of 2.2% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is down from 2.6% the prior year. Earnings ranks banks on that return over three years, and Bank7 Corp. scores 93/100 among other banks.
Bank7 Corp. reported revenue of $96.4M in fiscal year 2025, against $97.4M in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Bank7 Corp. scores 25/100 among other banks.
Bank7 Corp. funded 12.8% of its assets with shareholders' equity at the end of fiscal year 2025, holding $251.0M of equity against $2.0B of assets. Capital ranks banks on that cushion, and Bank7 Corp. scores 65/100 among other banks.
Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Bank7 Corp. scores 96/100 on it among other banks.
Not available for Bank7 Corp., and counted as zero in the overall score.
Bank7 Corp. reported net income of $43.1M in fiscal year 2025, against $45.7M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Bank7 Corp. scores 50/100 among other banks.
Bank7 Corp. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Bank7 Corp. generates $1.07 in operating cash flow ($46.1M OCF vs $43.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Bank7 Corp. generated $22.9M in revenue in Q2 2026. This represents a decrease of 6.3% from the same quarter a year earlier. Against the prior quarter it is down 12.4%.
Bank7 Corp. reported $8.3M in net income in Q2 2026. This represents a decrease of 24.8% from the same quarter a year earlier. Against the prior quarter it is down 30.5%.
Bank7 Corp. earned $0.87 per diluted share (EPS) in Q2 2026. This represents a decrease of 25.0% from the same quarter a year earlier. Against the prior quarter it is down 30.4%.
Not reported for Q2 2026.
Cash & Balance Sheet
Bank7 Corp. generated $5.4M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 38.2% from the same quarter a year earlier. Against the prior quarter it is down 61.5%.
Bank7 Corp. held $220.6M in cash as of Q2 2026; long-term debt is not reported for that period.
Bank7 Corp. paid $0.27 per share in dividends in Q2 2026. This represents an increase of 12.5% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Bank7 Corp.'s net profit margin was 36.4% in Q2 2026, showing the share of revenue converted to profit. This is down 9.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.5 percentage points.
Bank7 Corp.'s ROE was 3.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Bank7 Corp. repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Bank7 Corp. invested $2.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 220.5% from the same quarter a year earlier. Against the prior quarter it is down 17.8%.
Not reported for Q2 2026.
BSVN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.9M-6.3% | $26.2M+15.8% | $24.1M-0.1% | $25.2M+1.4% | $24.4M+0.2% | $22.6M-5.9% | $24.1M-14.0% | $24.9M+14.4% |
| SG&A Expenses | $6.2M+8.3% | $6.3M+19.9% | $5.8M+15.1% | $5.8M+9.3% | $5.7M+11.8% | $5.3M-0.2% | $5.0M+63.4% | $5.3M+8.6% |
| Interest Expense | $9.0M-10.2% | $9.6M-0.1% | $10.6M-0.4% | $10.7M-12.9% | $10.0M-10.4% | $9.6M-14.9% | $10.6M-4.6% | $12.3M+11.8% |
| Income Tax | $2.7M-25.9% | $3.8M+13.0% | $3.4M-6.5% | $3.3M-10.1% | $3.6M-3.5% | $3.4M-6.1% | $3.6M+633.9% | $3.7M+58.2% |
| Net Income | $8.3M-24.8% | $12.0M+16.2% | $10.8M-2.9% | $10.8M-7.9% | $11.1M-3.6% | $10.3M-8.4% | $11.1M+939.2% | $11.8M+50.0% |
| EPS (Basic) | $0.88-25.4% | $1.26+14.5% | $1.14-4.2% | $1.15-8.7% | $1.18-5.6% | $1.10-9.8% | $1.19+891.7% | $1.26+46.5% |
| EPS (Diluted) | $0.87-25.0% | $1.25+15.7% | $1.12-3.4% | $1.13-8.9% | $1.16-5.7% | $1.08-10.7% | $1.16+954.5% | $1.24+45.9% |
| Diluted Shares (Avg) | 10M+0.6% | 10M+0.5% | N/A | 10M+1.0% | 10M+1.9% | 10M+2.5% | N/A | 9M+2.4% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
BSVN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9B+4.2% | $1.9B+8.9% | $2.0B+12.9% | $1.9B+8.7% | $1.8B+9.1% | $1.8B+0.6% | $1.7B-1.8% | $1.7B-1.8% |
| Cash & Equivalents | $220.6M+0.8% | $246.7M+2.5% | $244.6M+4.5% | $241.8M+29.5% | $218.8M+4.2% | $240.6M+24.5% | $234.2M+29.4% | $186.7M+10.2% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $11.2M0.0% | $11.2M0.0% | $11.2M+32.5% | $11.2M+32.5% | $11.2M+32.5% | $11.2M+32.5% | $8.5M0.0% | $8.5M0.0% |
| Total Liabilities | $1.6B+2.7% | $1.7B+7.8% | $1.7B+12.2% | $1.6B+7.4% | $1.6B+7.5% | $1.6B-1.9% | $1.5B-4.7% | $1.5B-4.3% |
| Total Equity | $266.3M+14.9% | $259.8M+17.2% | $251.0M+17.7% | $241.7M+18.4% | $231.9M+21.5% | $221.7M+22.9% | $213.2M+25.2% | $204.2M+21.6% |
| Retained Earnings | $164.9M+23.8% | $159.1M+28.0% | $149.7M+28.7% | $141.5M+31.7% | $133.2M+36.1% | $124.3M+40.8% | $116.3M+47.3% | $107.4M+34.6% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
BSVN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.5M-20.7% | $16.6M+51.4% | $9.1M-30.8% | $16.6M+24.4% | $9.4M+16.0% | $11.0M-46.2% | $13.1M-19.0% | $13.4M+4.1% |
| Depreciation & Amortization | $290K+0.3% | $290K+15.5% | $289K+17.5% | $290K+14.2% | $289K+10.3% | $251K-14.9% | $246K-25.2% | $254K-21.4% |
| Stock-Based Compensation | N/A | $659K+1.1% | N/A | N/A | N/A | $652K+7.9% | N/A | N/A |
| Capital Expenditures | $2.0M+220.5% | $2.5M-11.2% | $1.1M-17.0% | $214K-65.1% | $639K-60.3% | $2.8M+319.6% | $1.3M+462.9% | $613K+62.6% |
| Free Cash Flow | $5.4M-38.2% | $14.2M+72.8% | $8.0M-32.3% | $16.4M+28.8% | $8.8M+34.8% | $8.2M-58.6% | $11.8M-26.0% | $12.7M+2.3% |
| Investing Cash Flow | $2.5M+103.5% | $18.6M+149.8% | -$67.4M-250.0% | -$34.1M+56.9% | -$71.8M-165.7% | -$37.3M-812.3% | $44.9M+12242.2% | -$79.3M+34.8% |
| Financing Cash Flow | -$36.1M-189.0% | -$33.1M-201.5% | $61.2M+680.6% | $40.4M-4.9% | $40.6M+140.4% | $32.6M+341.8% | -$10.5M-148.9% | $42.5M-48.0% |
| Dividends Paid | $2.6M+13.3% | $2.6M+13.4% | $2.6M+13.8% | $2.3M+16.7% | $2.3M+17.0% | $2.3M+16.7% | $2.2M+16.0% | $1.9M+33.0% |
| Share Buybacks | $0-100.0% | $1.2M+15.8% | $251K+4.1% | $9K+28.6% | $2K+100.0% | $1.0M+143.4% | $241K+65.1% | $7K-97.0% |
BSVN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 36.4%-9.0pp | 45.9%+0.2pp | 44.7%-1.3pp | 43.0%-4.3pp | 45.4%-1.8pp | 45.7%-1.3pp | 46.0%+42.2pp | 47.3%+11.2pp |
| Return on Equity | 3.1%-1.7pp | 4.6%0.0pp | 4.3%-0.9pp | 4.5%-1.3pp | 4.8%-1.3pp | 4.7%-1.6pp | 5.2%+4.6pp | 5.8%+1.1pp |
| Return on Assets | 0.4%-0.2pp | 0.6%0.0pp | 0.5%-0.1pp | 0.6%-0.1pp | 0.6%-0.1pp | 0.6%-0.1pp | 0.6%+0.6pp | 0.7%+0.2pp |
| Debt-to-Equity | 6.19-0.7x | 6.49-0.6x | 6.82-0.3x | 6.82-0.7x | 6.92-0.9x | 7.05-1.8x | 7.16-2.2x | 7.52-2.0x |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| FCF Margin | 23.8%-12.3pp | 54.1%+17.9pp | 33.1%-15.7pp | 65.0%+13.8pp | 36.0%+9.3pp | 36.3%-46.1pp | 48.8%-7.9pp | 51.2%-6.1pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Bank7 Corp. BSVN | FY2025 | $96.4M | $43.1M | 44.7% | $528.5M | 55/100 |
| Northfield Bancorp, Inc. NFBK | FY2025 | $154.3M | $796K | 0.5% | $639.4M | 29/100 |
| Arrow Financial Corp AROW | FY2025 | $139.5M | $44.0M | 31.5% | $700.0M | 29/100 |
| Bridgewater Bancshares, Inc. BWB | FY2025 | $143.4M | $46.1M | 32.1% | $577.5M | 59/100 |
| Red River Bancshares, Inc. RRBI | FY2025 | $125.5M | $42.8M | 34.1% | $680.9M | 55/100 |
| Flushing Financial Corp FFIC | FY2025 | $238.9M | $18.9M | 7.9% | $524.2M | 27/100 |
Where Bank7 Corp. Ranks
Frequently Asked Questions
What is Bank7 Corp.'s annual revenue?
Bank7 Corp. (BSVN) reported $96.4M in total revenue for fiscal year 2025. This represents a -1.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Bank7 Corp.'s revenue growing?
Bank7 Corp. (BSVN) revenue declined by 1.1% year-over-year, from $97.4M to $96.4M in fiscal year 2025.
Is Bank7 Corp. profitable?
Yes, Bank7 Corp. (BSVN) reported a net income of $43.1M in fiscal year 2025, with a net profit margin of 44.7%.
What is Bank7 Corp.'s net profit margin?
Bank7 Corp. (BSVN) had a net profit margin of 44.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Bank7 Corp. pay dividends?
Yes, Bank7 Corp. (BSVN) paid $1.02 per share in dividends during fiscal year 2025.
What is Bank7 Corp.'s return on equity (ROE)?
Bank7 Corp. (BSVN) has a return on equity of 17.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Bank7 Corp.'s free cash flow?
Bank7 Corp. (BSVN) generated $41.4M in free cash flow during fiscal year 2025. This represents a -18.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Bank7 Corp.'s operating cash flow?
Bank7 Corp. (BSVN) generated $46.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Bank7 Corp.'s total assets?
Bank7 Corp. (BSVN) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Bank7 Corp.'s capital expenditures?
Bank7 Corp. (BSVN) invested $4.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Bank7 Corp.'s debt-to-equity ratio?
Bank7 Corp. (BSVN) had a debt-to-equity ratio of 6.82 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Bank7 Corp.'s return on assets (ROA)?
Bank7 Corp. (BSVN) had a return on assets of 2.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Bank7 Corp.'s P/E ratio?
Bank7 Corp. (BSVN) trades at 12.6x earnings, its market capitalization divided by net income of $42.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $528.5M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Bank7 Corp.'s price-to-sales ratio?
Bank7 Corp. (BSVN) trades at 5.4x sales, its market capitalization divided by revenue of $98.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $528.5M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Bank7 Corp.'s Piotroski F-Score?
Bank7 Corp. (BSVN) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Bank7 Corp.'s earnings high quality?
Bank7 Corp. (BSVN) has an earnings quality ratio of 1.07x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Bank7 Corp.?
Bank7 Corp. (BSVN) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.